Legend Biotech Corp ADR (LEGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -282,600 | -158,100 | -520,118 | -445,724 | -407,196 |
| Depreciation Amortization | 28,900 | 21,400 | 20,451 | 18,392 | 13,917 |
| Accounts receivable | -5,700 | 93,800 | -98,980 | 50,320 | 24,590 |
| Accounts payable and accrued liabilities | 44,400 | 14,100 | -50,201 | 25,850 | 1,805 |
| Other Working Capital | -93,100 | 18,400 | -71,321 | 187,209 | 161,914 |
| Other Operating Activity | 207,900 | -133,600 | 326,893 | -37,328 | 6,505 |
| Operating Cash Flow | $-100,200 | $-144,000 | $-393,276 | $-201,281 | $-198,465 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -149,200 | 4,882,724 | 228,617 | 130,000 |
| PPE Investments | -28,600 | -14,100 | -20,084 | -20,927 | -42,193 |
| Purchase Of Investment | -5,000 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | -2,638 | -1,348 | -3,207 |
| Other Investing Activity | 743,200 | -687,300 | -4,769,854 | -284,782 | -282,790 |
| Investing Cash Flow | $709,600 | $-850,600 | $92,786 | $-77,092 | $-194,983 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,300 | 9,700 | 795,245 | 380,572 | 628,082 |
| Other Financing Activity | -3,600 | -4,000 | -3,755 | -2,596 | -1,419 |
| Financing Cash Flow | $-300 | $5,700 | $791,490 | $377,976 | $626,663 |
| Exchange Rate Effect | 6,100 | -2,100 | 682 | -2,510 | 34 |
| Beginning Cash Position | 286,700 | 1,277,700 | 786,031 | 688,938 | 455,689 |
| End Cash Position | 901,900 | 286,700 | 1,277,713 | 786,031 | 688,938 |
| Net Cash Flow | $615,200 | $-991,000 | $491,682 | $97,093 | $233,249 |
| Free Cash Flow | |||||
| Operating Cash Flow | -100,200 | -144,000 | -393,276 | -201,281 | -198,465 |
| Capital Expenditure | -28,600 | -14,100 | -20,084 | -20,927 | -42,197 |
| Free Cash Flow | -128,800 | -158,100 | -413,360 | -222,208 | -240,662 |